Literature DB >> 29606588

Nivolumab plus ipilimumab in advanced renal-cell carcinoma.

Ashray Gunjur.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29606588     DOI: 10.1016/S1470-2045(18)30257-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC).

Authors:  Shiyi Liu; Feiyan Wang; Wei Tan; Li Zhang; Fangfang Dai; Yanqing Wang; Yaqi Fan; Mengqin Yuan; Dongyong Yang; Yajing Zheng; Zhimin Deng; Yeqiang Liu; Yanxiang Cheng
Journal:  Cancer Cell Int       Date:  2020-10-27       Impact factor: 5.722

2.  Association of KDR mutation with better clinical outcomes in pan-cancer for immune checkpoint inhibitors.

Authors:  Yanan Cui; Pengpeng Zhang; Xiao Liang; Jiali Xu; Xinyin Liu; Yuemin Wu; Junling Zhang; Wei Wang; Fang Zhang; Renhua Guo
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

Review 3.  Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.

Authors:  T A Chan; M Yarchoan; E Jaffee; C Swanton; S A Quezada; A Stenzinger; S Peters
Journal:  Ann Oncol       Date:  2019-01-01       Impact factor: 32.976

4.  Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma.

Authors:  Yi Que; Xiao-Long Zhang; Ze-Xian Liu; Jing-Jing Zhao; Qiu-Zhong Pan; Xi-Zhi Wen; Wei Xiao; Bu-Shu Xu; Dong-Chun Hong; Tian-Hui Guo; Lu-Jun Shen; Wei-Jun Fan; Huo-Ying Chen; De-Sheng Weng; Hai-Rong Xu; Peng-Hui Zhou; Yi-Zhuo Zhang; Xiao-Hui Niu; Xing Zhang
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751

5.  Elevated serum soluble programmed cell death ligand 1 concentration as a potential marker for poor prognosis in small cell lung cancer patients with chemotherapy.

Authors:  Jianjun Jin; Jiming Si; Yuanhua Liu; Huanqin Wang; Ran Ni; Jing Wang
Journal:  Respir Res       Date:  2018-10-05

6.  CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC).

Authors:  Shiyi Liu; Feiyan Wang; Wei Tan; Li Zhang; Fangfang Dai; Yanqing Wang; Yaqi Fan; Mengqin Yuan; Dongyong Yang; Yajing Zheng; Zhimin Deng; Yeqiang Liu; Yanxiang Cheng
Journal:  Cancer Cell Int       Date:  2020-10-27       Impact factor: 5.722

Review 7.  Single-cell Analysis Technologies for Immuno-oncology Research: from Mechanistic Delineation to Biomarker Discovery.

Authors:  Zhiliang Bai; Graham Su; Rong Fan
Journal:  Genomics Proteomics Bioinformatics       Date:  2021-05-14       Impact factor: 7.691

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.